OPG/RANK/RANKL axis relation to cardiac iron-overload in children with transfusion-dependent thalassemia

Sci Rep. 2023 Aug 2;13(1):12568. doi: 10.1038/s41598-023-39596-3.

Abstract

OPG/RANK/RANKL axis was reportedly involved in initiating various diseases, especially bone and cardiovascular diseases. This study aimed to assess the relationship between some OPG, RANK, and RANKL polymorphisms and alleles and iron-overload-induced cardiomyopathy in children with transfusion-dependent thalassemia (TDT). This study included 80 TDT children and 80 age and sex-matched controls. Real-time PCR was done for rs207318 polymorphism for the OPG gene and rs1805034, rs1245811, and rs75404003 polymorphisms for the RANK gene, and rs9594782 and rs2277438 polymorphisms for the RANKL gene. Cardiac T2* MRI and ejection fraction (EF) were done to assess the myocardial iron status and cardiac function. In this study, there were no significant differences in frequencies of the studied polymorphisms between cases and controls (p > 0.05 in all). In TDT children, OPG rs2073618 (G > C) had a significant relation to myocardial iron overload (p = 0.02). Its C allele had significantly more frequent normal EF than its G allele (p = 0.04). RANK rs75404403 (C > DEL) had a significant relation to cardiac dysfunction (p = 0.02). Moreover, the C allele of that gene had significantly more frequent affected EF than its DEL allele (p = 0.02). The A allele of RANKL rs2277438 (G > A) had significantly less frequent severe cardiac iron overload than the G allele (p = 0.04). In conclusion, the OPG/ RANK/RANKL genes may act as genetic markers for iron-induced cardiomyopathy in TDT children. Some of the studied genes' polymorphisms and alleles were significantly related to myocardial iron overload and cardiac dysfunction in TDT children.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Heart Diseases*
  • Humans
  • Iron
  • Iron Overload* / genetics
  • Osteoprotegerin / genetics
  • Polymorphism, Single Nucleotide
  • RANK Ligand / genetics
  • Thalassemia* / complications
  • Thalassemia* / genetics

Substances

  • Osteoprotegerin
  • Iron
  • RANK Ligand